Kamata Co., Ltd.

Sunsho Pharmaceutical Co., Ltd. (HQ: Fuji City, Shizuoka Prefecture; CEO: Row Imamura), a leader in capsule development and manufacturing, is pleased to announce the successful completion of its acquisition of “Kamata Co., Ltd.” (HQ: Tokyo; CEO: Izumi Kamata), a prominent health food contract manufacturer specializing in soft capsules. Initially announced on December 11, 2023, Sunsho Pharmaceutical Co., Ltd. finalized the acquisition of Kamata Co., Ltd. as planned on January 5th, 2024. Sunsho Pharmaceutical Co., Ltd. committed to "being the best partner for everyone involved with Sunsho Pharmaceutical," is dedicated to improving global health through innovative development in health foods, pharmaceuticals, general foods, and general merchandise. This acquisition marks a significant milestone, positioning Kamata Co., Ltd. as a wholly owned subsidiary of Sunsho Pharmaceutical Co., Ltd. By combining the expertise and resources of Sunsho Pharmaceutical Co., Ltd. and Kamata Co., Ltd., the unified entity is poised to pioneer novel products and will continue to deliver the best products, services, and value-added solutions to our valued customers.